ILSI

Glyphosate Fact Sheet: Cancer and Other Health Concerns

Print Email Share Tweet
Posted on by Stacy Malkan

Glyphosate, a synthetic herbicide patented in 1974 by the Monsanto Company and now manufactured and sold by many companies in hundreds of products, has been associated with cancer and other health concerns. Glyphosate is best known as the active ingredient in Roundup-branded herbicides, and the herbicide used with “Roundup Ready” genetically modified organisms (GMOs).

Herbicide tolerance is the most prevalent GMO trait engineered into food crops, with some 90% of corn and 94% of soybeans in the U.S. engineered to tolerate herbicides, according to USDA data. A 2017 study found that Americans’ exposure to glyphosate increased approximately 500 percent since Roundup Ready GMO crops were introduced in the U.S in 1996. Here are some key facts about glyphosate:

Most Widely Used Pesticide

According to a February 2016 study, glyphosate is the most widely used pesticide: “In the U.S., no pesticide has come remotely close to such intensive and widespread use.” Findings include:

  • Americans have applied 1.8 million tons of glyphosate since its introduction in 1974.
  • Worldwide 9.4 million tons of the chemical has been sprayed on fields – enough to spray nearly half a pound of Roundup on every cultivated acre of land in the world.
  • Globally, glyphosate use has risen almost 15-fold since Roundup Ready GMO crops were introduced.

Cancer Concerns

The scientific literature and regulatory conclusions regarding glyphosate and glyphosate-based herbicides show a mix of findings, making the safety of the herbicide a hotly debated subject:

In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans” after reviewing years of published and peer-reviewed scientific studies. The team of international scientists found there was a particular association between glyphosate and non-Hodgkin lymphoma.

At the time of the IARC classification, the Environmental Protection Agency (EPA) was conducting a registration review. The EPA’s Cancer Assessment Review Committee (CARC) issued a report in September 2016 concluding that glyphosate was “not likely to be carcinogenic to humans” at doses relevant to human health. In publishing the CARC report, the EPA said that it was beginning work with the National Toxicology Program to investigate the mechanisms and toxic effects of glyphosate formulations. The agency then convened a Scientific Advisory Panel (SAP) in December 2016 to review the CARC report conclusion that glyphosate was not likely to be carcinogenic. The scientific advisory panel members were divided in their assessment of EPA’s work, with some finding the EPA erred in how it evaluated certain research. Additionally, the EPA’s Office of Research and Development determined that the agency’s Office of Pesticide Programs had not followed proper protocols in its evaluation of glyphosate. An ORD memo stated that the government scientists agreed in part with IARC and believed EPA was not properly following guidelines in coming to the conclusion that glyphosate was not likely to be carcinogenic. ORD said the evidence could be deemed to support a “likely” carcinogenic or “suggestive” evidence of carcinogenicity classification. Nevertheless the EPA issued a draft report on glyphosate in December 2017 continuing to hold that the chemical is not likely to be carcinogenic.

EFSA, ECA, WHO/FAO JMPR: The European Food Safety Authority and the European Chemicals Agency have said glyphosate is not likely to be carcinogenic to humans. But a March 2017 report by environmental and consumer groups argued that regulators relied improperly on research that was directed and manipulated by the chemical industry.

The WHO/FAO Joint Meeting on Pesticide Residues determined that glyphosate was unlikely to pose a carcinogenic risk to humans from exposure through the diet, though the finding was tarnished by conflict of interest concerns after it was revealed that certain members of the group, including its chair, worked for the International Life Sciences Institute, a group funded in part by Monsanto and one of its lobbying organizations.

California OEHHA: On March 28, 2017, the California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment confirmed that it would add glyphosate to California’s Proposition 65 list of chemicals known to cause cancer. Monsanto sued to block the action but the case was dismissed. In a separate case, the court found that California could not require cancer warnings for products containing glyphosate. On June 12, 2018, the United States District Court for the Eastern District of California denied the California Attorney General’s request for the court to reconsider the decision. The court found that California could only require commercial speech that disclosed “purely factual and uncontroversial information,” and the science surrounding glyphosate carcinogenicity was not proven.

Agricultural Health Study: A long-running U.S. government-backed prospective cohort study of farm families in Iowa and North Carolina has not found any connections between glyphosate use and non-Hodgkin lymphoma, but the researchers reported that “among applicators in the highest exposure quartile, there was an increased risk of acute myeloid leukemia (AML) compared with never users…” The most recent published update to the study was made public in late 2017.

New studies in 2019 report cancer links and concerns about the validity of the EPA classification:  

Cancer Lawsuits

More than 11,000 people have filed suit against Monsanto Company (now Bayer) alleging that exposure to Roundup herbicide caused them or their loved ones to develop non-Hodgkin lymphoma, and that Monsanto covered up the risks. As part of the discovery process, Monsanto has had to turn over millions of pages of its internal records. We are posting these Monsanto Papers as they become available here. For news and tips about the ongoing legislation, see Carey Gillam’s Roundup Trial Tracker. The first two trials ended with juries ruling that Monsanto’s weed killer was a substantial contributing factor in causing the plaintiffs to develop non-Hodgkin lymphoma, and giving large awards for liability and damages.  

Monsanto influence in research: In March 2017, the federal court judge unsealed some internal Monsanto documents that raised new questions about Monsanto’s influence on the EPA process and about the research regulators rely on. The documents suggest that Monsanto’s long-standing claims about the safety of glyphosate and Roundup do not necessarily rely on sound science as the company asserts, but on efforts to manipulate the science.

A study for the European Parliament published January 2019 asserts that the EU approval of glyphosate was based on plagiarized text from Monsanto. The study found plagiarism in 50.1 percent of chapters dealing with the assessment of published studies on health risks related to glyphosate in Germany’s Federal Institute for Risk Assessment, including whole paragraphs and entire pages of plagiarized text.

More information about scientific interference:

Endocrine Disruption and Other Health Concerns

Some research suggests that glyphosate may be an endocrine disruptor. It has also been linked to liver disease, birth defects and reproductive problems in laboratory animals; and may kill beneficial gut bacteria and damage the DNA in human embryonic, placental and umbilical cord cells. A 2019 study in a Nature journal reported increases in obesity, reproductive and kidney diseases, and other problems in the second- and third-generation offspring of rats exposed to glyphosate. See the study and Washington State University press release.

Many scientists have raised concerns about the health risks of glyphosate. See:

Recent studies have shown adverse biological effects from low-dose exposures to glyphosate at levels to which people are routinely exposed.

  • A birth cohort study in Indiana published in 2017 – the first study of glyphosate exposure in US pregnant women using urine specimens as a direct measure of exposure – found detectable levels of glyphosate in more than 90% of the pregnant women tested and found the levels were significantly correlated with shortened pregnancy lengths.
  • A 2018 ecological and population study conducted in Argentina found high concentrations of glyphosate in the soil and dust in agricultural areas that also reported higher rates of spontaneous abortion and congenital abnormalities in children, suggesting a link between environmental exposure to glyphosate and reproductive problems. No other relevant sources of pollution were identified.
  • A 2017 study associated chronic, very low-level glyphosate exposures to non-alcoholic fatty liver disease in rats. According to the researchers, the results “imply that chronic consumption of extremely low levels of a GBH formulation (Roundup), at admissible glyphosate-equivalent concentrations, are associated with marked alterations of the liver proteome and metabolome,” the biomarkers for NAFLD.
  • A 2018 rat study conducted by the Ramazzini Institute reported that low-dose exposures to Roundup at levels considered safe significantly altered the gut microbiota in some of the rat pups. Another 2018 study reported that higher levels of glyphosate administered to mice disrupted the gut microbiota and caused anxiety and depression-like behaviors.
  • A 2018 rat study by Argentinian researchers linked low-level perinatal glyphosate exposures to impaired female reproductive performance and congenital anomalies in the next generation of offspring.

Glyphosate has also been linked by recent studies to harmful impacts on bees and monarch butterflies.

Desiccation

Some farmers use glyphosate on non-GMO crops such as wheat, barley, oats, and lentils to dry down the crop ahead of harvest in order to accelerate the harvest. This practice, known as desiccation, may be a significant source of dietary exposure to glyphosate.

Glyphosate Found in Food: U.S. Drags Its Feet on Testing

The USDA quietly dropped a plan to start testing food for residues of glyphosate in 2017. Internal agency documents obtained by U.S. Right to Know show the agency had planned to start testing over 300 samples of corn syrup for glyphosate in April 2017. But the agency killed the project before it started. The U.S. Food and Drug Administration began a limited testing program in 2016, but the effort was fraught with controversy and internal difficulties and the program was suspended in September 2016. Both agencies have programs that annually test foods for pesticide residues but both have routinely skipped testing for glyphosate.

Before the suspension, one FDA chemist found alarming levels of glyphosate in many samples of U.S. honey, levels that were technically illegal because there have been no allowable levels established for honey by the EPA. Here is a recap of news about glyphosate found in food:

Pesticides in Our Food: Where’s the Safety Data?

USDA data from 2016 shows detectable pesticide levels in 85% of more than 10,000 foods sampled, everything from mushrooms to grapes to green beans. The government says there are little to no health risks, but some scientists say there is little to no data to back up that claim. See “Chemicals on our food: When “safe” may not really be safe: Scientific scrutiny of pesticide residue in food grows; regulatory protections questioned,” by Carey Gillam (11/2018).

ILSI Wields Stealthy Influence for Food, Agrichemical Industries

Print Email Share Tweet
Posted on by Stacy Malkan

The International Life Sciences Institute (ILSI) is a corporate-funded nonprofit organization founded in 1978 by Alex Malaspina, a former senior vice president at Coca-Cola who worked for the company from 1969 until 2001. ILSI claims on its website to bring together scientists from industry, government and academia to “provide science that improves public health.” However, evidence suggests that ILSI Global and its branches operate as fronts to influence science and policies in ways that benefit corporate interests over public health.

ILSI is funded by the food and agrichemical industries, according to internal documents obtained by U.S. Right to Know.

U.S. Right to Know has also reported just how far the influence of ILSI and its top operatives extends. In 2016, Carey Gillam reported that ILSI’s founder, Alex Malaspina, was able to ask for and receive input and guidance from a top official at the U.S. Centers for Disease Control and Prevention (CDC) on how to address actions by the World Health Organization that were hurting the food and beverage industry.

The emails, obtained via state freedom of information requests, reveal that Dr. Barbara Bowman, director of a CDC division charged with preventing heart disease and stroke, tried to help Malaspina find inroads to influence WHO officials to back off anti-sugar talk. Bowman suggested people and groups for Malaspina to talk to, and solicited his comments on some CDC summaries of reports, the emails show. (Bowman stepped down after articles were published reporting on these ties.)

Coca-Cola has kept close ties with ILSI ever since Malaspina founded the group. In 2015, ILSI’s president was Rhona Applebaum, Coke’s chief health and science officer. Applebaum retired from Coke in November 2015 after revelations that the company funded a group called the Global Energy Balance Network to spin the obesity story. Coca-Cola has gone to great lengths to try to shift blame for obesity away from sugary drinks. For more on Coke’s obesity spin campaign, see articles from the New York Times and Associated Press.

ILSI soda controversy in China

Two papers published in January 2019 document how Coca-Cola and other corporations used ILSI to influence decades of Chinese science and public policy on obesity and diet-related illnesses such as Type 2 diabetes and hypertension.

On Jan. 9, 2019, The New York Times reported on the two new studies showing how Coca-Cola and other Western food and beverage giants “helped shape decades of Chinese science and public policy on obesity and diet-related diseases” by operating through ILSI to cultivate key Chinese officials “in an effort to stave off the growing movement for food regulation and soda taxes that has been sweeping the west.”

ILSI is so well-placed in China that it operates from inside the government’s Centre for Disease Control and Prevention in Beijing, the researchers reported. See:

ILSI glyphosate controversy

In May 2016, ILSI came under scrutiny after revelations that the chair of ILSI’s board of trustees, Alan Boobis, was at the same time the chairman of a UN panel that found Monsanto’s herbicide glyphosate unlikely to pose a cancer risk through diet.

ILSI has received at least $500,000 in donations from Monsanto, in addition to significant contributions from other chemical industry sources. Monsanto draws roughly a third of its $15 billion annual revenues from its Roundup branded glyphosate-based herbicide products.

The story and corporate funding of ILSI was first reported by Carey Gillam for U.S. Right to Know. The Guardian, Die Zeit, ARD and Horticulture Week have also covered the conflict of interest involving ILSI and the glyphosate review by the UN’s Joint Meeting on Pesticide Residues.

More on ILSI:

International Life Sciences Institute (ILSI) 2012 major donor list

“UCSD Hires Coke-Funded Researcher,” by Morgan Cook, San Diego Union-Tribune (9.29.2016)

“What is Going on at the CDC? Health Agency Ethics Need Scrutiny,” by Carey Gillam, The Hill (8.27.2016)

“More Coca-Cola Ties Seen Inside U.S. Centers for Disease Control,” by Carey Gillam, Huffington Post (8.1.2016)

“CDC Official Exits Agency After Coca-Cola Connections Come to Light,” by Carey Gillam, Huffington Post (12.6.2017)

“Beverage Industry Finds Friend Inside U.S. Health Agency,” by Carey Gillam, Huffington Post (6.28.2016)

“Conflict of Interest Concerns Cloud Glyphosate Review,” by Carey Gillam, U.S. Right to Know (5.12.2016)

“UN/WHO Panel in Conflict of Interest Row over Glyphosate Cancer Risk,” by Arthur Neslen, The Guardian (5.17.2016)

CDC SPIDER: Scientists complain of corporate influence at health agency

Print Email Share Tweet
Posted on by Stacy Malkan

By Carey Gillam

Concerns about the inner workings of the U.S. Centers for Disease Control and Prevention (CDC) have been mounting in recent months amid disclosures of cozy corporate alliances. Now a group of more than a dozen senior scientists have reportedly lodged an ethics complaint alleging the federal agency is being influenced by corporate and political interests in ways that short-change taxpayers.

A group calling itself CDC Scientists Preserving Integrity, Diligence and Ethics in Research, or CDC SPIDER, put a list of complaints in writing in a letter to the CDC Chief of Staff and provided a copy of the letter to the public watchdog organization U.S. Right to Know (USRTK). The members of the group have elected to file the complaint anonymously for fear of retribution.

“It appears that our mission is being influenced and shaped by outside parties and rogue interests… and Congressional intent for our agency is being circumvented by some of our leaders. What concerns us most, is that it is becoming the norm and not the rare exception,” the letter states. “These questionable and unethical practices threaten to undermine our credibility and reputation as a trusted leader in public health.”

The complaint cites among other things a “cover up” of the poor performance of a women’s health program called the Well-Integrated Screening and Evaluation for Woman Across the Nation, or WISEWOMAN. The program provides standard preventive services to help 40- to 64-year-old women reduce their risks for heart disease, and promote healthy lifestyles. CDC currently funds 21 WISEWOMAN programs through states and tribal organizations. The complaint alleges there was a coordinated effort within the CDC to misrepresent data given to Congress so that it appeared the program was involving more women than it actually was.

“Definitions were changed and data ‘cooked’ to make the results look better than they were,” the complaint states. “An ‘internal review’ that involved staff across CDC occurred and its findings were essentially suppressed so media and/or Congressional staff would not become aware of the problems.”
The letter mentions that Congresswoman Rosa DeLauro, a Democrat from Connecticut, who has been a proponent of the program, has made inquiries to CDC regarding the data. A spokesman for her office, confirmed as much.

The complaint also alleges that staff resources that are supposed to be dedicated to domestic programs for Americans are instead being directed to work on global health and research issues.

And the complaint cites as “troubling” the ties between soft drink giant Coca-Cola Co., an advocacy group backed by Coca-Cola, and two high-ranking CDC officials – Dr. Barbara Bowman who directed the CDC’s Division for Heart Disease and Stroke Prevention until retiring in June, and Dr. Michael Pratt, senior Advisor for Global Health in the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) at the CDC.

Bowman, retired after revelations of what the complaint called an “irregular” relationship with Coca-Cola and the nonprofit corporate interest group set up by Coca-Cola called the International Life Sciences Institute (ILSI). Email communications obtained through Freedom of Information Act (FOIA) requests by USRTK revealed that in her CDC role, Bowman had been communicating regularly with – and offering guidance to – a leading Coca-Cola advocate seeking to influence world health authorities on sugar and beverage policy matters.

Emails also suggested that Pratt has a history of promoting and helping lead research funded by Coca-Cola while being employed by the CDC. Pratt also has been working closely with ILSI, which advocates for the agenda of beverage and food industries, emails obtained through FOIA showed. Several research papers co-written by Pratt were at least partly funded by Coca-Cola, and Pratt has received industry funding to attend industry-sponsored events and conferences.

Last month, Pratt took a position as Director of the University of California San Diego Institute for Public Health. Next month, ILSI is partnering with the UCSD to hold a forum related to “energy balance behavior,” planned for November 30 to December 1 of this year. One of the moderators is another CDC scientist, Janet Fulton, Chief of the CDC’s Physical Activity and Health Branch. Pratt is on annual leave from the CDC during his stint in San Diego, according to the CDC.

The forum fits into the messaging of “energy balance” that Coca-Cola has been pushing. Consumption of sugar-laden foods and beverages is not to blame for obesity or other health problems; a lack of exercise is the primary culprit, the theory goes.

Experts in the nutrition arena have said that the relationships are troubling because the mission of the CDC is protecting public health, and yet certain CDC officials appear to be close with an industry that, studies say, is linked to about 180,000 deaths per year worldwide, including 25,000 in the United States. The CDC is supposed to be addressing rising obesity rates among children, not advancing beverage industry interests.

CDC spokeswoman Kathy Harben would not address what the agency might be doing, if anything, in response to the SPIDER complaint, but she said the agency makes use of a “full range of federal ethics statutes, regulations, and policies” that apply to all federal employees.”

“CDC takes seriously its responsibility to comply with the ethics rules, inform employees about them, and take steps to make it right any time we learn that employees aren’t in compliance,” Harben said. “We provide regular training to and communicate with staff on how to comply with ethics requirements and avoid violations.”

The SPIDER group complaint ends with a plea for CDC management to address the allegations; to “do the right thing.”

Let’s hope someone is listening.

This article was originally published in Huffington Post. 

What Is Going on at the CDC? Health Agency Ethics Need Scrutiny

Print Email Share Tweet
Posted on by Carey Gillam

Officials at the Centers for Disease Control and Prevention have their hands full these days. An epidemic of obesity has hit Americans hard, raising the risks for heart disease, stroke, type 2 diabetes and certain types of cancer. Childhood obesity is a particular prevalent problem.

Last year, World Health Organization (WHO) Director General Margaret Chan said the marketing of full-sugar soft drinks was a key contributor to rising obesity rates among children, suggesting restrictions on sugar-rich beverage consumption.

Though the beverage industry has strongly objected, several U.S. cities have been passing, or trying to pass, taxes on sugary sodas to discourage consumption. Since Berkeley, California became the first U.S. city to levy a soda tax in 2014, consumption dropped more than 20 percent in some areas of the city, according to a report published August 23 by the American Journal of Public Health. A Mexican soda tax correlated with a similar drop in soda purchases, according to research published earlier this year. One would expect the efforts would be heartily applauded by the CDC. And indeed, earlier this year a CDC research report said more aggressive measures were needed to convince Americans to cut back on sugary drinks.

But behind the scenes, mounting evidence suggests that rather than cracking down on the soda industry, high-ranking officials within the CDC’s National Center for Chronic Disease Prevention and Health Promotion are instead cozying up to beverage giant Coca-Cola and its industry allies, even in some cases aiding the industry as it argues that sodas are not to blame.

At least one internal ethics complaint over industry influence was lodged this month, according to a source inside the CDC. And more may be coming as a group of scientists within the CDC reportedly are attempting to push back against a culture cultivating close ties with corporate interests.

One recent focus of scrutiny has been the ties between Michael Pratt, Senior Advisor for Global Health in the CDC’s disease prevention unit, and Coca-Cola’s brainchild — the nonprofit corporate interest group called the International Life Sciences Institute (ILSI.) ISLI was founded by Coca-Cola scientific and regulatory affairs leader Alex Malaspina in 1978, and continues to advocate for the agenda of beverage and food industries. Some in the scientific community see ILSI as little more than a front group aimed at advancing the interests of those industries with little regard for public well-being.

Still, ILSI’s money and influence are well known at the CDC, and Pratt’s work with ILSI is a prime example. Documents show that Pratt has a long history of promoting and helping lead research backed by Coca-Cola and ILSI.

One item at the top of the agenda for Coca-Cola and ILSI is gaining acceptance for the concept of energy balance. Rather than focusing on reducing consumption of sugar-laden foods and beverages to help control obesity and other health problems, policy makers should be focusing on a lack of exercise as the primary culprit, the industry says. That type of strategic spin is expected from companies that make money off those sugary foods and drinks. They’re protecting their profits.

But it’s harder to understand how the CDC can sign off on Pratt’s involvement in the industry effort. This public employee, presumably drawing a taxpayer-funded paycheck, has spent the last few years working in a range of roles near and dear to the industry: He co-authored a Latin America health and nutrition study and related papers funded in part by Coca-Cola and ILSI; he has been acting as a scientific “advisor” to ILSI North America, serving on an ILSI committee on “energy balance and active lifestyle.”

Until his activities came under scrutiny, he was listed as a member of the ILSI Research Foundation Board of Trustees (his bio was removed from the website earlier this month). Pratt also served as an advisor to an international study of childhood obesity funded by Coca-Cola. And for roughly the last year or more he has held a position as a professor at Emory University, a private research university in Atlanta that has received millions of dollars from Coca-Cola entities.

The CDC says Pratt’s temporary assignment at Emory has ended. But now Pratt is headed to the University of San Diego (UCSD) to take the role of Director of the UCSD Institute for Public Health. And coincidentally — or not — ISLI is partnering with the UCSD on a “unique forum” related to “energy balance behavior” planned for November 30 to December 1 of this year. One of the moderators is another CDC scientist, Janet Fulton, Chief of the CDC’s Physical Activity and Health Branch.

When asked about Pratt’s work for these other outside interests, and asked if he had received approval and ethics clearance for the activities, CDC spokeswoman Kathy Harben said only that Pratt will be doing his work at UCSD while on annual leave from the CDC. If the public wants to know if Pratt has properly disclosed conflicts of interest and received approvals for his outside work, we have to file a Freedom of Information request, Harben said.

That is not an especially promising suggestion given that documents recently supplied by the CDC related to employee ties to Coca-Cola were only turned over after large swaths of communications were blacked out. Those emails pertained to former Pratt colleague Dr. Barbara Bowman, who was director of the CDC’s Division for Heart Disease and Stroke Prevention until departing the agency this summer amid scrutiny of her ties to Coca-Cola. Bowman was instrumental in helping direct CDC funds to a pet project that ILSI is working on with the U.S. Department of Agriculture to develop a “branded foods database.”

Email communications obtained that were not redacted showed that Bowman, a former Coca-Cola nutritionist, maintained a close connection with the company and ILSI as she rose in rank at the CDC. The emails show that Bowman was happy to help the beverage industry cultivate political sway with the World Health Organization (WHO) as it tried to beat back regulation on sugary soft drinks. The emails showed ongoing communications regarding ILSI and beverage industry interests. Bowman “retired” in late June after those emails became public.

ILSI has a history of working to infiltrate public health organizations. A report by a consultant to WHO found that ILSI was infiltrating the organization with scientists, money and research to garner favor for industry products and strategies. ILSI was also accused of attempting to undermine WHO tobacco control efforts on behalf of the tobacco industry.

So should the public be concerned? The CDC says no. But we at the consumer group U.S. Right to Know believe the answer is an emphatic yes. The mission of the CDC is to protect public health, and it is problematic for agency officials to collaborate with a corporate interest that has a track record of downplaying the health risks of its products. Questions about the alliances and the actions of some CDC officials are growing, and it is time the public received some answers.

(This article first appeared in The Hill – http://www.thehill.com/blogs/pundits-blog/healthcare/293482-what-is-going-on-at-the-cdc-health-agency-ethics-need-scrutiny)

More Coca-Cola Ties Seen Inside U.S. Centers For Disease Control

Print Email Share Tweet
Posted on by Carey Gillam

In June, Dr. Barbara Bowman, a high-ranking official within the Centers for Disease Control and Prevention, unexpectedly departed the agency, two days after information came to light indicating that she had been communicating regularly with – and offering guidance to – a leading Coca-Cola advocate seeking to influence world health authorities on sugar and beverage policy matters.

Now, more emails suggest that another veteran CDC official has similarly close ties to the global soft drink giant. Michael Pratt, Senior Advisor for Global Health in the National Center for Chronic Disease Prevention and Health Promotion at the CDC, has a history of promoting and helping lead research funded by Coca-Cola. Pratt also works closely with the nonprofit corporate interest group set up by Coca-Cola called the International Life Sciences Institute (ILSI), emails obtained through Freedom of Information requests show.

Pratt did not respond to questions about his work, which includes a position as a professor at Emory University, a private research university in Atlanta that has received millions of dollars from the Coca-Cola Foundation and more than $100 million from famed longtime Coca-Cola leader Robert W. Woodruff and Woodruff’s brother George. Indeed, Coca-Cola’s financial support for Emory is so strong that the university states on its website that “it’s unofficially considered poor school spirit to drink other soda brands on campus.”

CDC spokeswoman Kathy Harben said Pratt had been on a “temporary assignment” to Emory University but his work at Emory “is completed and he is now back on staff at CDC.” Emory University websites still show Pratt as currently assigned as a professor there, however.

Regardless, research by consumer advocacy group U.S. Right to Know shows Pratt is another high-ranking CDC official with close ties to Coca-Cola. And experts in the nutrition arena said that because the mission of the CDC is protecting public health, it is problematic for agency officials to collaborate with a corporate interest that has a track record of downplaying the health risks of its products.

“These alignments are worrisome because they help provide legitimacy to industry-friendly spin,” said Andy Bellatti, a dietitian and founder of Dietitians for Professional Integrity.

One key message Coca-Cola has been pushing is “Energy Balance.”Consumption of sugar-laden foods and beverages is not to blame for obesity or other health problems; a lack of exercise is the primary culprit, the theory goes. “There is increasing concern about overweight and obesity worldwide, and while there are many factors involved, the fundamental cause in most cases is an imbalance between calories consumed and calories expended,” Coca-Cola states on its website.

“The soda industry is keen on deflecting the conversation away from the well-documented negative health effects of sugar-sweetened beverages and onto physical activity,” said Bellatti.

The messaging comes at a time when leading global health authorities are urging a crack-down on consumption of sugary food and beverages, and some cities are implementing added taxes on sodas to try to discourage consumption. Coca-Cola has been fighting back in part by providing funding for scientists and organizations who back up the company with research and academic presentations.

Pratt’s work with the industry appears to fit into that messaging effort. Last year he co-authored a Latin America health and nutrition studyand related papers funded in part by Coca-Cola and ILSI to investigate the diets of individuals in Latin American countries and to establish a database for studying the “complex relationship existing between energy imbalance, obesity and associated chronic diseases…” Pratt also has been acting as a scientific “advisor” to ILSI North America, serving on an ILSI committee on “energy balance and active lifestyle.” And he is a member of the ILSI Research Foundation Board of Trustees. He also served as an advisor to an international study of childhood obesity funded by Coca-Cola.

ILSI’s North American branch, whose members include Coca-Cola, PepsiCo Inc., Dr Pepper Snapple Group and more than two dozen other food industry players, states as its mission the advancement of the “understanding and application of science related to the nutritional quality and safety of the food supply.” But some independent scientists and food industry activists consider ILSI to be a front group aimed at advancing the interests of the food industry. It was founded by Coca-Cola scientific and regulatory affairs leader Alex Malaspina in 1978. ILSI has had a long and checkered relationship with the World Health Organization, working at one time closely with its Food and Agricultural Organization (FAO) and with WHO’s International Agency for Research on Cancer and the International Programme on Chemical Safety.

But a report by a consultant to WHO found that ILSI was infiltrating WHO and FAO with scientists, money and research to garner favor for industry products and strategies. ILSI was also accused of attempting to undermine WHO tobacco control efforts on behalf of the tobacco industry.

One April 2012 email exchange obtained through a Freedom of Information request shows Pratt as part of a circle of professors communicating with Rhona Applebaum, then Coca-Cola’s chief scientific and regulatory officer, about difficulties getting cooperation on a study in Mexico from that country’s National Institute of Public Health. The Institute would not “play ball because of who was sponsoring the study,” according to an email Peter Katzmarzyk, a professor of exercise science at the Pennington Biomedical Research Center at Louisiana State University, sent to the group. Appelbaum defended the integrity of the research and expressed anger at the situation, writing “So if good scientists take $$$ from Coke – what? – they’re corrupted? Despite the fact they’re advancing public good?” In the email exchange Pratt offered to assist “especially if these issues continue to arise.”

Emails show Pratt’s communication with Applebaum, who also served a term as ILSI’s president, continued through at least 2014, including discussion of work for “Exercise is Medicine,” an initiative launched in 2007 by Coca-Cola and for which Pratt serves as an advisory board member.

Applebaum left the company in 2015 after the Global Energy Balance Network that she helped establish came under public scrutiny amid allegations that it was little more than a Coca-Cola propaganda group. Coca-Cola poured roughly $1.5 million into the establishment of the group, including a $1 million grant to the University of Colorado. But after Coca-Cola’s ties to the organization were made public in an article in The New York Times, and after several scientists and public health authorities accused the network of “peddling scientific nonsense,” the university returned the money to Coca-Cola. The network disbanded in late 2015 after emails surfaced that detailed Coca-Cola’s efforts to use the network to influence scientific research on sugary drinks.

Coca-Cola has been particularly zealous in recent years in working to counter concerns about consumption of beverages with high sugar content and links between sugary beverages and obesity and other diseases. The New York Times reported last year that Coke’s chief executive, Muhtar Kent, admitted that the company had spent almost $120 million since 2010 to pay for academic health research and for partnerships with major medical and community groups involved in curbing the obesity epidemic.

Marion Nestle, a professor of nutrition, food studies and public health at New York University and the author of “Soda Politics,” said that when CDC officials work so closely with industry, there is a conflict of interest risk the CDC should consider.

“Officials of public health agencies run the risk of cooptation, capture, or conflict of interest when they have close professional ties with companies whose job it is to sell food products, regardless of the effects of those products on health,” said Nestle.

Pratt’s ties to Coca-Cola and ILSI are similar to those seen with Bowman. Bowman, who directed the CDC’s Division for Heart Disease and Stroke Prevention, worked early in her career as a senior nutritionist for Coca-Cola and later while at the CDC co-authored an edition of a book called Present Knowledge in Nutrition as “a publication of the International Life Sciences Institute.“ The emails between Bowman and Malaspina showed ongoing communications regarding ILSI and beverage industry interests.

During Bowman’s tenure, in May 2013, ILSI and other organizers invited Bowman and the CDC to participate in a project ILSI was engaged in with the U.S. Department of Agriculture to develop a “branded foods database.” Travel costs for Bowman would be paid by ILSI, the invitation stated. Bowman did agree to participate and the CDC provided funding, at least $25,000, Harben confirmed, to support the database project. The 15-member steering committee for the project held six ILSI representatives, documents show.

Both Bowman and Pratt have worked under the direction of Ursula Bauer, director of the National Center for Chronic Disease Prevention and Health Promotion. After U.S. Right to Know publicized emails about Bowman’s ties to ILSI and Coca-Cola, Bauer defended the relationship in an email to her employees, saying “it’s not unusual for Barbara – or any of us- to correspond with others who have similar interests in our areas of work…”

Still, Bowman announced an unexpected retirement from CDC two days after the emails were made public. CDC initially denied she had departed the agency, but Harben said this week that was only because it took some time to “process” Bowman’s transition to retirement.

The relationships raise fundamental questions about how close is too close when public officials collaborate with industry interests that can conflict with public interests.

Yoni Freedhoff, MD, an assistant professor of family medicine at the University of Ottawa and founder of the Bariatric Medical Institute, said there is a real danger to when public health officials become too close with corporate players.

“Until we recognize the inherent risks of conflicts of interest with the food industry and public health, there is near certainty that these conflicts will influence the nature and strength of recommendations and programs in ways that will be friendly to industries whose products contribute to the burden of illness those same recommendations and programs are meant to address,” Freedhoff said.

(Post first appeared in The Huffington Post )

Follow Carey Gillam on Twitter:

CDC Official Exits Agency After Coca-Cola Connections Come to Light

Print Email Share Tweet
Posted on by Carey Gillam

Barbara bio pic (1)

By Carey Gillam

A veteran leader within the Centers for Disease Control and Prevention announced her immediate departure from the agency on Thursday, two days after it came to light that she had been offering guidance to a leading Coca-Cola advocate who was seeking to influence world health authorities on sugar and beverage policy matters.

In her role at CDC, Dr. Barbara Bowman, director of CDC’s Division for Heart Disease and Stroke Prevention, has been involved in a range of health policy initiatives for the division charged with providing “public health leadership.” She began her career at the CDC in 1992.

Bowman’s boss, Ursula Bauer, Director, National Center for Chronic Disease Prevention and Health Promotion, sent an email to staff members after my June 28 story in this blog revealed the Coca-Cola connections. In that email, she confirmed the accuracy of the report, and while she defended Bowman’s actions, she said the “perception that some readers may take from the article is not ideal.” She also warned employees to avoid similar actions, saying the situation “serves as an important reminder of the old adage that if we don’t want to see it on the front page of the newspaper then we shouldn’t do it.”

Bowman’s exit was announced through internal emails. Bowman told colleagues in a CDC email sent Thursday that she had decided to retire “late last month.” She made no reference to the revelations about her connections with Coca-Cola or any other concerns.

Bauer sent a separate email applauding Bowman’s work with CDC. “Barbara has served with distinction and has been a strong, innovative, dedicated and supportive colleague. She will be greatly missed by our center and CDC,” Bauer said in the email.

Bowman’s departure comes at a time when several questions about Bowman and her department are dogging the agency, according to sources inside the CDC. In addition to the questions about ties to Coca-Cola, which is actively trying to push back on policies regulating or reining in soft drinks, there are questions about the efficacy and transparency of a program known as WiseWoman, which provides low-income, under-insured or uninsured women with chronic disease risk factor screening, lifestyle programs, and referral services in an effort to prevent cardiovascular disease. The departure also comes a day after the organization I work for – U.S. Right to Know – filed another FOIA seeking additional communications.

The Coca-Cola connections date back decades for Bowman, and tie her to former top Coca-Cola executive and strategist Alex Malaspina. Malaspina, with Coca-Cola’s help, founded the controversial industry group International Life Sciences Institute (ILSI). Bowman also worked early in her career as a senior nutritionist for Coca-Cola, according to sources, and she co-authored an edition of a book called Present Knowledge in Nutrition as “a publication of the International Life Sciences Institute.”

ILSI’s reputation has been called into question several times for the strategies it has employed to try to sway public policy on health-related issues.

Email communications obtained by U.S. Right to Know through state Freedom of Information requests revealed that Bowman appeared happy to help Malaspina, who formerly was Coca-Cola’s top scientific and regulatory affairs leader, and the beverage industry cultivate political sway with the World Health Organization. The emails showed Malaspina, representing the interests of Coca-Cola and ISLI, complaining that the World Health Organization was giving a cold shoulder ILSI. The email strings include reports of concerns about Coca-Cola’s new Coca-Cola Life, sweetened with stevia, and criticisms that it still contained more sugar than daily limit recommended by WHO.

The communications came as the beverage industry has been reeling from a series of actions around the world to rein in consumption of sugary soft drinks due to concerns about links to obesity and type 2 diabetes.

A critical blow came last June when World Health Organization (WHO) Director General Margaret Chan said the marketing of full-sugar soft drinks was a key contributor to rising child obesity around the world, especially in developing countries. WHO published a new sugar guideline in March 2015, and Chan suggested restrictions on sugar-rich beverage consumption.

Mexico already implemented its own soda tax in 2014, and many cities in the U.S. and around the world are currently considering such restrictions or disincentives, like added taxes, while others have already done so. The Mexican soda tax has correlated with a drop in soda purchases, according to research published earlier this year.

CDC spokeswoman Kathy Harben said earlier this week that the emails did not necessarily represent a conflict or problem. But Robert Lustig, Professor of Pediatrics in the Division of Endocrinology at the University of California, San Francisco, said ILSI is a known “front group for the food industry.” And he pointed out that the CDC has yet to take a stance on limiting sugar consumption, despite the WHO concerns about links to disease.

The email exchanges show that Bowman did more than simply respond to questions from Malaspina. She also initiated emails and forwarded information she received from other organizations. Many of Bowman’s emails with Malaspina were received and sent through her personal email account, though in at least one of the communications, Bowman forwarded information from her CDC email address to her personal email account before sharing it with Malaspina.

ILSI has had a long and checkered relationship with the World Health Organization, working at one time closely with its Food and Agricultural Organization (FAO) and with WHO’s International Agency for Research on Cancer and the International Programme on Chemical Safety.

But a report by a consultant to WHO found that ILSI was infiltrating WHO and FAO with scientists, money and research to garner favor for industry products and strategies. ILSI was also accused of attempting to undermine WHO tobacco control efforts on behalf of the tobacco industry.

WHO eventually distanced itself from ILSI. But questions about ILSI influence erupted again this spring when scientists affiliated with ILSI participated in an evaluation of the controversial herbicide glyphosate, issuing a decision favorable to Monsanto Co. and the pesticide industry.

Follow Carey Gillam on Twitter: www.twitter.com/careygillam

(This article first appeared in The Huffington Post http://www.huffingtonpost.com/carey-gillam/cdc-official-exits-agency_b_10760490.html)

Beverage Industry Finds Friend Inside U.S. Health Agency

Print Email Share Tweet
Posted on by Stacy Malkan

This article was first published by Huffington Post. 

By Carey Gillam 

It’s been a rough year for Big Soda, sellers of those sugary soft drinks that kids (and adults) love to chug.

A June 16 decision by city leaders in Philadelphia to impose a “soda tax” as a means to discourage consumption of beverages seen as unhealthy is only the latest in a string of bad news for companies like Coca-Cola and PepsiCo, which have seen soft drink sales steadily declining. Nervous investors drove shares in those companies lower after the Philadelphia move in recognition of what is but the latest evidence that consumers, lawmakers and health experts are connecting sweetened beverages to a range of health problems, including obesity and type 2 diabetes.

Last year San Francisco passed a law requiring ads for sugary drinks to include warnings about the possible negative health effects associated with the products.

A critical blow came last June when World Health Organization (WHO) Director General Margaret Chan said the marketing of full-sugar soft drinks was a key contributor to rising child obesity around the world, especially in developing countries. WHO published a new sugar guideline in March 2015, and Chan suggested restrictions on sugar-rich beverage consumption.

Mexico already implemented its own soda tax in 2014, and many cities in the U.S. and around the world are currently considering such restrictions or disincentives, like added taxes, while others have already done so. The Mexican soda tax has correlated with a drop in soda purchases, according to research published earlier this year.

It’s no surprise that the beverage industry, which reaps billions of dollars annually from soft drink sales, has been fearing – and fighting against – this shifting sentiment.

But what is surprising is one of the places where the beverage industry has sought, and apparently garnered, some help —- from a top official with the Centers for Disease Control and Prevention, whose mission in part is to prevent obesity, diabetes, and other health problems.

Email communications obtained by U.S. Right to Know through state Freedom of Information requests detail how a leading beverage and food industry advocate last year was able to ask for and input and guidance from Dr. Barbara Bowman, director of CDC’s Division for Heart Disease and Stroke Prevention, on how to address World Health Organization actions that were hurting the beverage industry.

Bowman leads a CDC division charged with providing “public health leadership” and works with states to promote research and grants to prevent and manage risk factors that include obesity, diabetes, heart disease and stroke. 

But the emails between Bowman and Alex Malaspina, a former Coca-Cola scientific and regulatory affairs leader and founder of the industry-funded International Life Sciences Institute (ILSI), show that Bowman also appeared happy to help the beverage industry cultivate political sway with the World Health Organization.

Emails from 2015 detail how Malaspina, representing the interests of Coca-Cola and the food industry, reached out to Bowman to complain that the World Health Organization was giving a cold shoulder to the chemical and food industry-funded group known as ILSI, which Malaspina founded in 1978. The email strings include reports of concerns about Coca-Cola’s new Coca-Cola Life, sweetened with stevia, and criticisms that it still contained more sugar than daily limit recommended by WHO.

The emails include reference to the WHO’s call for more regulation on sugary soft drinks, saying they were contributing to rising obesity rates among children, and complain about Chan’s comments.

“Any ideas how we can have a conversation with WHO?” Malaspina writes in a June 26, 2015 email to Bowman. He forwards her an email string that includes top executives from Coca-Cola and ILSI and expresses worry about negative reports about products with high sugar content, and sugary soda tax plans in Europe. In the email string, Malaspina says the WHO actions can have “significant negative consequences on a global basis.”

“The threat to our business is serious,” Malaspina writes in the email chain he sends to Bowman. On the email chain are Coca-Cola Chief Public Affairs and Communications Officer Clyde Tuggle as well as Coca-Cola’s Chief Technical Officer Ed Hays.

Directly he tells Bowman that officials at WHO “do not want to work with industry.” And says: “Something must be done.”

Bowman replies that someone with Gates or “Bloomberg people” may have close connections that could open a door at WHO. She also suggests he try someone at PEPFAR program, a U.S. government-backed program that makes HIV/AIDS drugs available through the sub-Saharan Africa. She tells him that “WHO is key to the network.” She writes that she “will be in touch about getting together.”

In a subsequent June 27, 2015 email, Malaspina thanks her for the “very good leads” and says “we would want WHO to start working with ILSI again… and for WHO to not only consider sugary foods as the only cause of obesity but to consider also the life style changes that have been occurring throughout the Universe.” He then suggests he and Bowman meet for dinner soon.

The fact that a high-level U.S. health official is communicating in this way with a beverage industry leader appears improper, according to Marion Nestle, author of the book “Soda Politics” and a professor of nutrition, food studies, and public health at New York University.

“These emails suggest that ILSI, Coca-Cola, and researchers funded by Coca-Cola have an ‘in’ with a prominent CDC official,” Nestle said. “The official appears to be interested in helping these groups organize opposition to “eat less sugar” and “disclose industry funding” recommendations. The invitation to dinner suggests a cozy relationship… This appearance of conflict of interest is precisely why policies for engagement with industry are needed for federal officials.”

But CDC spokeswoman Kathy Harben said the emails do not necessarily represent a conflict or problem.

“It is not unusual for CDC to be in touch with people on all sides of an issue.” Harben said.

Robert Lustig, Professor of Pediatrics in the Division of Endocrinology at the University of California, San Francisco, said ILSI is a known “front group for the food industry.” Lustig said he finds it “interesting” that the CDC has yet to take a stance on limiting sugar consumption, despite the WHO concerns about links to disease. Lustig directs UCSF’s WATCH program (Weight Assessment for Teen and Child Health), and is co-founder of the non-profit Institute for Responsible Nutrition.

Neither Bowman nor Malaspina responded to requests for comment.

The email exchanges show that Bowman did more than simply respond to questions from Malaspina. She also initiated emails and forwarded information she received from other organizations. Many of Bowman’s emails with Malaspina were received and sent through her personal email account, though in at least one of the communications, Bowman forwarded information from her CDC email address to her personal email account before sharing it with Malaspina.

In a February 2015 email from Bowman to Malaspina she shared an email she had received from a USDA official with the subject line “FOR YOUR REVIEW: Draft Principles from Dec 8 Public Private Partnerships Meeting.” The email from David Klurfeld, national program leader for human nutrition at the USDA’s Agricultural Research Service, quoted an article from the BMJ medical journal stressing a need for public/private partnerships, and included a quote about a “strong tide of sanctimony in British public health.” Bowman tells Malaspina: “This may be of interest. Check out the BMJ correspondence especially.”

In a March 18, 2015 email from Bowman to Malaspina she forwarded an email regarding the new policy brief to curb global sugar consumption she received from the World Cancer Research Fund International. Malaspina then shared the communications with Coca-Cola officials and others.

In a separate March 2015 email, Bowman sent Malaspina some CDC summaries of reports and says she would appreciate his “thoughts and comments.”

Bowman, who holds a PhD in human nutrition and nutritional biology, has worked at the CDC since 1992, and has held several senior leadership positions there. She was appointed director of the Division for Heart Disease and Stroke Prevention in the National Center for Chronic Disease Prevention and Health Promotion at CDC in February 2013.

Malaspina has also had a long career in his field of expertise. The veteran Coca-Cola executive founded ILSI in 1978 with help from Coca-Cola, Pepsi and other food industry players and ran it until 1991. ILSI has had a long and checkered relationship with the World Health Organization, working at one time closely with its Food and Agricultural Organization (FAO) and with WHO’s International Agency for Research on Cancer and the International Programme on Chemical Safety.

But a report by a consultant to WHO found that ILSI was infiltrating WHO and FAO with scientists, money and research to garner favor for industry products and strategies. ILSI was also accused of  attempting to undermine WHO tobacco control efforts on behalf of the tobacco industry.

WHO eventually distanced itself from ILSI. But questions about ILSI influence erupted again this spring when scientists affiliated with ILSI participated in an evaluation of the controversial herbicide glyphosate, issuing a decision favorable to Monsanto Co. and the pesticide industry.

Carey Gillam is a veteran journalist and research director for U.S. Right to Know, a non-profit consumer education group. Follow her on Twitter @CareyGillam

Glyphosate ‘Revolution’ Growing — Consumers Want Answers

Print Email Share Tweet
Posted on by Carey Gillam

By Carey Gillam 

They’re calling it a glyphosate “revolution.” Consumers around the world are waking up to the fact that they’re living in a world awash in the weed-killing pesticide known as glyphosate. And they don’t like it one bit.

Over the last several years, some scientists have been warning that the long-touted environmental and health safety promises associated with glyphosate, the chief ingredient in Monsanto’s branded Roundup, may not be as iron-clad as asserted. Last year’s finding by the World Health Organization’s cancer research experts that glyphosate “probably” is a human carcinogen sparked a firestorm that only grows more heated by the day. Consumers in the United States, Europe and elsewhere are now demanding that regulators step up and restrict or ban glyphosate herbicides – the most widely used in the world – to protect both human health and the environment.

Glyphosate’s current license for use in the EU expires in June, and the European Union recently delayed making a decision on extending the registration due to the controversy.

The U.S. Environmental Protection Agency is similarly stymied. Last month a petition signed by thousands of Americans was presented to EPA demanding glyphosate be revoked in the United States. A group of U.S. scientists and activists has a meeting scheduled with the EPA on June 14 to try to convince the regulatory agency it needs to restrict or ban glyphosate. The agency is trying to finish a long-overdue new risk assessment for the chemical.

More fuel was added to the fire this week when a coalition of scientists and activists working through what they call “The Detox Project” announced that testing at a University of California San Francisco laboratory revealed glyphosate in the urine of 93 percent of a sample group of 131 people. The group said it used a method known as liquid chromatography-mass spectrometry or LC/MS/MS, to analyze urine and water samples. (The group said it found no glyphosate residues in tap water.) Further data from this public bio-monitoring study will be released later in 2016, according to the group overseeing the testing.

In the urine tests, glyphosate was detected at an average level of 3.096 parts per billion (PPB) with children having the highest levels with an average of 3.586 PPB, according to Henry Rowlands, director of the Detox Project.

Private groups have already been testing foods for glyphosate residues in the absence of testing by the Food and Drug Administration (FDA), and they have found residues in a variety of products on grocery store shelves. Glyphosate is used widely in production of numerous food crops, most notably with biotech crops genetically engineered to tolerate being sprayed directly with glyphosate. The FDA said in February it would start some limited testing for food residues, but has provided few details.

Michael Antoniou, a molecular geneticist from London who has been studying glyphosate concerns for years and is supporting the Detox Project, said more testing is needed. “With increasing evidence from laboratory studies showing that glyphosate-based herbicides can result in a wide range of chronic illnesses through multiple mechanisms, it has become imperative to ascertain the levels of glyphosate in food and in as large a section of the human population as possible,” he said in a statement.

The Detox Project is billing itself as a platform for consumers to submit their personal bodily fluids for testing. The urine testing was commissioned by the Organic Consumers Association, and one of the objectives is to gather research to determine if eating an organic diet has any effect on the level of synthetic chemicals in people’s bodies.

Earlier in May test results for urine samples from members of the European Parliament also showed glyphosate in their systems.

Monsanto and leading agrichemical scientists say glyphosate is among the safest of pesticides on the market, and essential to robust food production. They point to decades of safety studies and regulatory approvals around the world. They say even if glyphosate residues are in food, water and bodily fluids, they aren’t harmful.

Support for that argument came last week from a United Nations panel of scientists who proclaimed that a thorough review of the scientific literature made it clear that glyphosate was probably not carcinogenic to humans. But the finding was quickly pilloried as tainted because the chairman of the panel, Alan Boobis, also helps run the International Life Science Institute (ILSI), which has received more than $500,000 from Monsanto and other large donations from additional agrichemical interests.

The uproar over glyphosate shows no sign of easing. Next month, the consumer group Moms Across America is launching a “National Toxin Free Town Tour” to crisscross the country to advocate for a pull back on glyphosate and other chemicals seen as harmful.

To be sure, glyphosate, which is used in hundreds of herbicide products globally, is only one of many chemicals pervasive in today’s environment. It seems that everywhere we turn, worrisome chemicals are found in our food supply, our water, our air, our land. Heightened consumer awareness about glyphosate comes as consumers are increasingly demanding more information and tighter controls on many aspects of how their food is produced.

Those behind the Detox Project have an agenda, just as do many of the group’s pushing for regulatory restrictions, and those supporting continued use of glyphosate. But the concern about glyphosate’s impact on human health and the environment cannot be swept aside.

On one of its webpages, Monsanto uses the motto “We May Not Have All the Answers But We Keep on Searching.”

The consumer groups pushing for more testing and more regulatory controls on glyphosate are saying the same thing.

This article originally appeared in Huffington Post. Want more food for thought? Sign up for the USRTK Newsletter.

Carey Gillam is a veteran former Reuters journalist and now research director for U.S. Right to Know, a food industry research group.  Follow Carey Gillam on Twitter: www.twitter.com/careygillam

Conflict of Interest Concerns Cloud Glyphosate Review

Print Email Share Tweet
Posted on by Carey Gillam

By Carey Gillam

It’s been a little more than a year since the World Health Organization’s (WHO) cancer research experts upended the agrichemical industry’s favorite child. The group, the International Agency for Research on Cancer (IARC) declared the globe’s most widely used herbicide – glyphosate – to be a probable human carcinogen.

Since then, Monsanto Co., which draws roughly a third of its $15 billion in annual revenues from its Roundup branded glyphosate-based herbicide products, (and much of the rest from glyphosate-tolerant crop technology) has been on a mission to invalidate the IARC finding. Through an army of foot soldiers that include industry executives, public relation professionals and public university scientists, the company has called for a rebuke of IARC’s work on glyphosate.

How successful those efforts will or will not be is still an open question. But some answers are expected following a meeting being held this week in Geneva, Switzerland. An “international expert scientific group” known as JMPR is reviewing IARC’s work on glyphosate, and the results are expected to offer regulators around the world a guide for how to view glyphosate.

The group, officially known as the Joint FAO-WHO Meeting on Pesticide Residues (JMPR), is administered jointly by the Food and Agriculture Organization of the United Nations (FAO) and WHO. JMPR meets regularly to review residues and analytical aspects of pesticides, to estimate maximum residue levels, and to review toxicological data and estimate acceptable daily intakes (ADIs) for humans.

After this week’s meeting, set to run from May 9-13, JMPR is expected to issue a series of recommendations that will then go to the FAO/WHO Codex Alimentarius Commission. The Codex Alimentarius was established by FAO and the World Health Organization develops harmonized international food standards as a means to protect consumer health and promote fair practices in food trade.

The meeting comes as both European and U.S. regulators are wrestling with their own assessments and how to react to the IARC classification. It also comes as Monsanto looks for backing for its claims of glyphosate safety.

Glyphosate is not just a lynchpin for sales of the company’s herbicides but also for its genetically modified seeds designed to tolerate being sprayed with glyphosate. The company also is currently defending itself against several lawsuits in which farmworkers and others allege they contracted cancer linked to glyphosate and that Monsanto knew of, but hid, the risks. And, a rebuke of IARC’s glyphosate classification could help the company in its lawsuit against the state of California, which aims to stop the state from following the IARC classification with a similar designation.

Depending on the result of the JMPR, the Codex will decide on any actions necessary regarding glyphosate, said WHO spokesperson Tarik Jasarevic.

“It is the JMPR’s function to conduct risk assessment for agricultural use and assessing the health risks to consumers from residues found in food,” said Jasarevic

The outcome of the JMPR meeting is being watched closely by a number of environmental and consumer groups that want to see new safety standards for glyphosate. And not without some worry. The coalition, which includes the Natural Resources Defense Council and Friends of the Earth, has expressed concern about apparent conflicts of interest on the expert advisory panel. Some individuals appear to have financial and professional ties to Monsanto and the chemical industry, according to the coalition.

The coalition specifically cited concerns with member ties to the nonprofit International Life Sciences Institute (ILSI), which is funded by Monsanto and other chemical, food and drug companies. The Institute’s board of trustees includes executives from Monsanto, Syngenta, DuPont, Nestle and others, while its list of member and supporting companies includes those and many more global food and chemical concerns.

Internal ILSI documents, obtained by a state public records request, suggest that ILSI has been generously funded by the agrichemical industry. One document that appears to be ILSI’s 2012 major donor list shows total contributions of $2.4 million, with more than $500,000 each from CropLife International and from Monsanto.

“We have significant concerns that the committee will be unduly influenced by the overall pesticide industry and particularly Monsanto- the largest producer of glyphosate in the world,” the coalition told WHO in a letter last year.

One such JMPR expert is Alan Boobis, professor of biochemical pharmacology and director of the toxicology unit in the faculty of medicine at Imperial College London. He is a member and a past chairman of the board of trustees of ILSI, vice-president of ILSI Europe and chair of ILSI.

Another member is Angelo Moretto, Director of the International Centre for Pesticides and Health Risks Prevention at “Luigi Sacco” Hospital of the ASST Fatebenefratelli Sacco, in Milan, Italy. The coalition said that Moretto has been involved in various projects with ILSI and has served as a member of the steering team for an ILSI project on risks of chemical exposures financed by agrichemical companies that included Monsanto.

Another is Aldert Piersma, a senior scientist at the National Institute for Public Health and the Environment in the Netherlands and an advisor to projects of ILSI’s Health and Environmental Sciences Institute.

In all the JMPR list of experts totals 18. Jasarevic said that the roster of experts are chosen from a group of individuals who expressed interest in being involved, and all are “independent and are selected based on their scientific excellence, as well as on their experience in the field of pesticide risk assessment.”

Aaron Blair, a scientist emeritus at the National Cancer Institute and the chairman of the IARC group that made the glyphosate classification, has defended IARC’s work as based on a thorough scientific review. He said he had no concerns to discuss regarding the  JMPR review of IARC’s work.

“I am sure the evaluation by the joint FAO/WHO group will make the reasons for their evaluation clear, which is what is critical for the press and public,” he said.

The world is waiting.